Moderna Eyes December For U.S. Permission For Vaccine Use

The video discusses the timeline for emergency use authorization of coronavirus vaccines, focusing on Moderna's plans. Moderna aims to complete clinical trials by November and seeks emergency use approval by December. The company plans to produce 20 million doses by the end of 2020 and 500 million doses in 2021. Other companies like Pfizer are also seeking emergency authorization.

What is the condition for the COVID-19 vaccine to receive emergency use authorization by the end of the year?

• Completion of a clinical trial in December

• Public demand for the vaccine

• Approval from the World Health Organization

• Completion of a clinical trial in November

Which company expects to ask for emergency authorization for its vaccine by late November?

• Novavax

• AstraZeneca

• Pfizer

• Johnson & Johnson

If Moderna sees positive results, when could the federal government authorize emergency use of their vaccine?

• December

• January

• October

• November

How many doses does Moderna plan to produce by the end of 2021?

• 100 million

• 500 million

• 50 million

• 1 billion

By the end of this year, how many doses does Moderna expect to produce?

• 50 million

• 10 million

• 100 million

• 20 million